跳至主要内容
临床试验/NCT02037412
NCT02037412终止4 期

Impact of Ticagrelor on the Endothelial Healing Following Drug-eluting Stent Implantation in the Patients With Acute Coronary Syndrome

Yonsei University1 个研究点 分布在 1 个国家目标入组 148 人开始时间: 2014年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
终止
入组人数
148
试验地点
1
主要终点
Stent re-endothelialization

研究概览

简要总结

The investigators hypothesized that ticagrelor may enhance endothelial healing after DES implantation by increasing adenosine concentrations by the inhibition of adenosine uptake into erythrocytes, compared to clopidogrel. Thus, the investigators will evaluate the extent of endothelialization (stent strut coverage) and neointimal hyperplasia (neointimal thickness) 3 months after DES implantation by optical coherence tomography (OCT)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients ≥ 20 years old
  • Patients who are hospitalized and expected to undergo PCI for acute coronary syndrome, including acute myocardial infarction and unstable angina.

排除标准

  • Age > 80 years
  • Cardiogenic shock or unstable patients
  • Increased risk of bleeding, anemia, thrombocytopenia
  • A need for oral anticoagulation therapy
  • Pregnant women or women with potential childbearing
  • Life expectancy < 1 year

研究组 & 干预措施

Ticagrelor Arm

Experimental

Ticagrelor Arm

干预措施: Ticagrelor (Drug)

Clopidogrel Arm

Active Comparator

Clopidogrel Arm

干预措施: Clopidogrel (Drug)

结局指标

主要结局

Stent re-endothelialization

时间窗: Three months after stent implantation

Percentage of stent coverage measured by OCT

Neointimal hyperplasia

时间窗: Three months after stent implantation

Neointimal thickness measured by OCT

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验